The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Identifying factors that influence the decision to reduce, delay, or discontinue treatment due to chemotherapy-induced peripheral neuropathy: A community-centered approach.
 
Rotana M Radwan
No Relationships to Disclose
 
Daniel Louis Hertz
Research Funding - Disarm Therapeutics
Other Relationship - Advocates for Universal DPD/DPYD Testing (AUDT)
(OPTIONAL) Uncompensated Relationships - PEPID; Saladax Biomedical
 
Erin Hickey
No Relationships to Disclose
 
Hetal Ravikumar Vachhani
No Relationships to Disclose
 
Maryam B. Lustberg
Honoraria - Novartis
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; Lilly; Pfizer
Other Relationship - Cynosure/Hologic
 
John F.P Bridges
Honoraria - Pfizer
Consulting or Advisory Role - Boehringer Ingelheim
Travel, Accommodations, Expenses - Boehringer Ingelheim
 
Roy Sabo
No Relationships to Disclose
 
Vanessa Sheppard
No Relationships to Disclose
 
Teresa M. Salgado
Employment - Stage Analytics (I)
Leadership - Stage Analytics (I)
Stock and Other Ownership Interests - AngioDynamics (I); Invesco S&P (I); Moderna Therapeutics (I); Organogenesis (I); Vertex (I)
Research Funding - Boehringer Ingelheim